Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02162628 · ClinicalTrials.gov registry record
Exair® Versus Native Tissue Repair for Prolapse
A clinical trial, sponsored by Coloplast A/S.
- Terminated
- Registry status
- 79
- Enrollment target
NCT02162628 is a clinical trial that was terminated before completion, run by Coloplast A/S. The registered enrollment target is 79 participants.
The verdict
NCT02162628 was terminated before completion, sponsored by Coloplast A/S.
- TERMINATED
- Registry status
- 79 participants
- Enrollment target
Study Summary
The purpose of this study is to compare safety and effectiveness of the Exair Prolapse Repair System for treatment of pelvic organ prolapse to traditional native tissue repair through 36 months of follow-up.
Interventions
- DEVICE Exair Prolapse Repair System
- PROCEDURE Total Native Tissue Repair
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2014-08 |
| Est. Completion | 2015-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02162628
The ClinicalTrials.gov registry entry for NCT02162628 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Coloplast A/S, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Exair Prolapse Repair System is the first listed.
NCT02162628 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02162628 about?
NCT02162628 is a clinical study titled "Exair® Versus Native Tissue Repair for Prolapse". The purpose of this study is to compare safety and effectiveness of the Exair Prolapse Repair System for treatment of pelvic organ prolapse to traditional native tissue repair through 36 months of follow-up.
What is the current status of trial NCT02162628?
This trial is currently terminated. The enrollment target is 79 participants. The study started on 2014-08. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02162628?
The interventions under investigation include: Exair Prolapse Repair System (DEVICE), Total Native Tissue Repair (PROCEDURE).
Who is sponsoring clinical trial NCT02162628?
This trial is sponsored by Coloplast A/S, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.